Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Treatment of children persistently infected with hepatitis B virus: seroconversion or suppression Price N; Boxall EHJ Antimicrob Chemother 2007[Dec]; 60 (6): 1189-92We have reviewed the current strategies regarding the treatment of persistent hepatitis B virus (HBV) in children and compared these with adult strategies. The options for achieving suppression of viral DNA replication versus hepatitis B e antigen to antibody seroconversion have been evaluated. The results of studies in different geographical locations have been confounded by HBV genotypes, as it is now clear that some genotypes respond better to treatment than others. Consideration needs to be given as to whether optimal treatment strategies developed for adults are directly applicable to children. In children, early seroconversion to allow improved long-term outcomes should be considered rather than embarking on the long-term complexities of managing patients on a combination of antiviral drugs to achieve viral suppression.|Antiviral Agents/*therapeutic use[MESH]|Child[MESH]|Child, Preschool[MESH]|DNA Replication/drug effects[MESH]|Drug Therapy, Combination[MESH]|Hepatitis B Antibodies/blood[MESH]|Hepatitis B virus/*drug effects/immunology[MESH]|Hepatitis B, Chronic/*drug therapy/virology[MESH]|Humans[MESH]|Infant[MESH]|Interferon-alpha/*therapeutic use[MESH]|Lamivudine/*therapeutic use[MESH]|Treatment Outcome[MESH] |
